Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: A proof-of-concept study

PURIFI Study Group

Research output: Contribution to journalArticle

53 Scopus citations

Fingerprint Dive into the research topics of 'Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: A proof-of-concept study'. Together they form a unique fingerprint.

Medicine & Life Sciences